Jazz Pharmaceuticals to buy cannabinoid medicine developer GW Pharmaceuticals for $7.2B
February 03, 2021 at 09:20 AM EST
The company being acquired has developed the first and only FDA-approved prescription cannabidiol medicine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|